Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
H2020_ITN_ORBITAL_Partner
Ahmed, Zubair
(Principal Investigator)
Inflammation and Ageing
Overview
Fingerprint
Research output
(3)
Research output
Research output per year
2024
2024
2024
3
Article
Research output per year
Research output per year
3 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2024
Design of liposomal nanocarriers with a potential for combined dexamethasone and bevacizumab delivery to the eye
Farooq, U.
,
O'Reilly, N. J.
,
Ahmed, Z.
,
Gasco, P.
,
Singh, T. R. R.
,
Behl, G.
,
Fitzhenry, L.
&
McLoughlin, P.
,
10 Apr 2024
,
In:
International Journal of Pharmaceutics.
654
,
10 p.
, 123958.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Dexamethasone
100%
Nanocarrier
84%
Liposome
72%
Ocular
50%
Drug
27%
22
Downloads (Pure)
Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina
Thareja, A.
,
Leigh, T.
,
Hakkarainen, J. J.
,
Hughes, H.
,
Alvarez-lorenzo, C.
,
Fernandez-Trillo, F.
,
Blanch, R.
&
Ahmed, Z.
,
20 Jul 2024
,
In:
International Journal of Pharmaceutics.
660
, 124305.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Polyacetylene Polymer
100%
penetratin
95%
dexamethasone 21-phosphate
86%
Dexamethasone
50%
Retina
47%
13
Downloads (Pure)
Prospects and limitations of cumate‑inducible lentivirus as a tool for investigating VEGF‑A‑mediated pathology in diabetic retinopathy
Lelyte, I.
,
Rao, V. R.
,
Kalesnykas, G.
,
Ragauskas, S.
,
Kaja, S.
&
Ahmed, Z.
,
21 Jun 2024
,
In:
Scientific Reports.
14
,
12 p.
, 14325.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Lentivirus
100%
Diabetic Retinopathy
88%
Vascular Endothelial Growth Factor A
72%
Pathology
53%
Intravitreal Injections
28%
15
Downloads (Pure)